Business Context and Reporting Period
This Form 8-K is a current report filed by iBio, Inc. on April 18, 2013, with events reported as of April 22, 2013. The filing addresses a notice of delisting received from NYSE MKT LLC and the announcement of a technology transfer milestone.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. However, it references the Company's Form 10-Q for the quarter ended December 31, 2012, noting that the Exchange determined the Company has sustained losses substantial in relation to its operations or financial resources, raising questions about its ability to continue operations.
Material Changes and Listing Status
- Delisting Notice: On April 18, 2013, iBio, Inc. received notice from NYSE MKT LLC that it is not in compliance with Section 1003(a)(iv) of the Company Guide due to substantial sustained losses and impaired financial condition.
- Compliance Timeline: The Company must submit a plan of compliance by May 6, 2013, demonstrating an ability to regain compliance by July 15, 2013. Failure to do so will result in delisting procedures.
- Management Stance: Management believes it can provide a satisfactory plan to regain compliance by the specified deadlines.
Outlook, Risks, and Unusual Items
- Technology Milestone: On April 22, 2013, the Company announced the achievement of a technology transfer milestone verified by an independent third-party laboratory.
- Primary Risk: The immediate risk is the potential delisting from NYSE MKT if the compliance plan is not accepted by the Exchange.
- Financial Contingency: The Exchange's review indicates the Company's financial condition is impaired, posing a risk to its ability to meet obligations as they mature.
Investor Verification Checklist
- Verify the specific financial figures in the Form 10-Q for the quarter ended December 31, 2012, to understand the magnitude of the losses cited by the Exchange.
- Monitor the submission and acceptance status of the compliance plan due May 6, 2013.
- Review the details of the technology transfer milestone announced on April 22, 2013, to assess its potential impact on future revenue or partnerships.
- Check for any subsequent filings regarding the Company's liquidity position and ability to fund operations through July 15, 2013.